Wuhan General Group (China), Inc. Share Price Other OTC
Equities
WUHN
US9825691051
Biotechnology & Medical Research
Sales 2011 | 128M 10.21B | Sales 2012 | 80.38M 6.44B | Capitalization | 1.33M 107M |
---|---|---|---|---|---|
Net income 2011 | -3M -240M | Net income 2012 | -10M -801M | EV / Sales 2011 | 0.55 x |
Net Debt 2011 | 62.49M 5B | Net Debt 2012 | 100M 8.01B | EV / Sales 2012 | 1.26 x |
P/E ratio 2011 |
-1.56
x | P/E ratio 2012 |
-0.12
x | Employees | - |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 76.65% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 18/07/88 |
Willem Jonker
DFI | Director of Finance/CFO | - | 04/10/20 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 21/01/19 | |
Jeff Robinson
FOU | Founder | - | 18/07/88 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |